Clinical trials
Phase 2 Dyslipidemias trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 2 |
| Centro Universitario de Ciencias de la Salud, Mexico | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Hospital Nacional Homeopático, Mexico | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 6 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Lipoatrophic | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Glucose Metabolism Disorders | 2 |
| Hyperlipoproteinemias | 1 |
| Insulin Resistance | 1 |
| Lipid Metabolism Disorders | 1 |
| Metabolic Diseases | 1 |
| Metabolic Syndrome | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.